Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis

    June 2022 in “ Frontiers in Endocrinology ”
    Lingzhi Chen, Yiyuan Liu, Jiehui Cai, Zeqi Ji, Juan Zou, Yaokun Chen, Jinyao Wu, Daitian Zheng, Jiehua Zheng, Yexi Chen, Zhiyang Li
    Image of study
    TLDR Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.
    The document is a scientometric analysis of 2,118 publications from 2011 to 2020, studying the relationship between androgen receptors (ARs) and breast cancer. The United States was the leading contributor to this research, with the University of Texas MD Anderson Cancer Center being the most productive institution. The research focus shifted over time from the relationship between molecular types of breast cancer and AR gene expression to the mechanism and signal pathway of AR's action in breast cancer, and then to clinical applications such as therapy and prognosis. The study suggests that ARs may be a potential prognostic index and therapeutic target for some types of breast cancer, including Triple-Negative Breast Cancer (TNBC). The document also highlights that AR overexpression can induce resistance to Tamoxifen, a common breast cancer treatment, and suggests Enzalutamide as a possible treatment for AR-expressing TNBC. Future research should focus on emerging themes such as “androgen receptor expression”, “growth-factor receptor”, “neoadjuvant chemotherapy”, and “tumor-infiltrating lymphocyte”.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  37 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  125 upvotes 1 year ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 10 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Similar Research

    5 / 1000+ results